ArticleEuropean journal of medical research2025
Decoding dynamic lipase trajectory patterns and in-hospital mortality in acute pancreatitis: insights from machine learning in intensive care units.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Management and Prediction of Acute Pancreatitis Severity Using AI: A Surgical Perspective.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSerum lipase levels are crucial biomarkers in acute pancreatitis (AP), yet their dynamic patterns and prognostic implications remain incompletely understood. This study aimed to identify distinct lipase trajectory phenotypes and evaluate their association with in-hospital mortality in AP patients.
methodsWe conducted a retrospective analysis of 834 AP patients from the MIMIC-IV database using latent class trajectory modeling (LCTM) to identify distinct lipase trajectory phenotypes. Cox regression models, adjusted for demographics, comorbidities, clinical therapies, and critical illness markers, were employed to assess the association between trajectory classes and in-hospital mortality.
resultsThree distinct lipase trajectory phenotypes were identified: Class 1 (n = 543) with consistently low levels, Class 2 (n = 51) with extremely high and variable levels, and Class 3 (n = 240) with moderately elevated levels. Class 2 patients were significantly older (66.8 ± 17.6 years) and had higher comorbidity burden (CCI: 5.6 ± 3.0). In-hospital mortality rates were 12.2%, 17.6%, and 19.2% for Classes 1, 2, and 3, respectively. After comprehensive adjustment, both Class 2 (HR: 2.21, 95% CI 1.04-4.71, p = 0.042) and Class 3 (HR: 1.61, 95% CI 1.08-2.40, p = 0.022) showed significantly higher mortality risk compared to Class 1.
conclusionsDynamic lipase trajectory patterns in AP patients demonstrate distinct phenotypes with significant prognostic value for in-hospital mortality. These findings suggest that monitoring lipase trajectories may enhance risk stratification and guide clinical management in AP patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.